Overview
Cardiac rehabilitation is a program designed to help those with heart problems, such as a previous heart attack or heart surgery, to restore cardiac health.
Cardiac rehabilitation is not always prescribed… read more
Overview
Camzyos is approved by the U.S. Food and Drug Administration (FDA) to treat adults with symptomatic New York Heart Association class 2 and 3 obstructive hypertrophic cardiomyopathy (HCM). Camzyos is also known by…
Overview
Myqorzo is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), a condition in which the heart muscle becomes…